
Single Dose Radiotherapy Services Market Report 2026
Global Outlook – By Type (Internal Beam Radiotherapy, External Beam Radiotherapy), By Application (Prostate Cancer, Breast Cancer), By Service Provider (Specialized Cancer Institutes, Radiotherapy Centers) - Market Size, Trends, And Global Forecast 2026-2035
Single Dose Radiotherapy Services Market Overview
• Single Dose Radiotherapy Services market size has reached to $1.6 billion in 2025 • Expected to grow to $2.27 billion in 2030 at a compound annual growth rate (CAGR) of 7.1% • Growth Driver: Increasing Cancer Prevalence Drives Growth In Single Dose Radiotherapy Services Market • Market Trend: Innovative Solutions Enhance Single Dose Radiotherapy Services Market's Precision And Efficiency • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.What Is Covered Under Single Dose Radiotherapy Services Market?
Single-dose radiotherapy services refer to a cancer treatment approach where a single high dose of radiation is administered to a tumor in one session. These services offer convenience by reducing hospital visits, providing quick symptom relief, and are often used in palliative care to improve quality of life. The main types of single-dose radiotherapy services are internal beam radiotherapy and external beam radiotherapy. Internal beam radiotherapy refers to a type of treatment, also known as brachytherapy, that involves placing a radioactive source directly inside or near the tumor. This method delivers high doses of radiation to the cancerous area while minimizing exposure to surrounding healthy tissues. The various applications involved are prostate cancer and breast cancer and various service providers include specialized cancer institutes and radiotherapy centers.
What Is The Single Dose Radiotherapy Services Market Size and Share 2026?
The single dose radiotherapy services market size has grown strongly in recent years. It will grow from $1.6 billion in 2025 to $1.73 billion in 2026 at a compound annual growth rate (CAGR) of 8.1%. The growth in the historic period can be attributed to limited access to conventional radiotherapy, rising cancer incidence, high patient preference for outpatient care, growth in radiotherapy equipment availability, early adoption of single dose protocols.What Is The Single Dose Radiotherapy Services Market Growth Forecast?
The single dose radiotherapy services market size is expected to see strong growth in the next few years. It will grow to $2.27 billion in 2030 at a compound annual growth rate (CAGR) of 7.1%. The growth in the forecast period can be attributed to advancements in precision radiotherapy technology, integration of AI and robotics, increasing reimbursement coverage, growth in oncology-focused healthcare centers, rising adoption in emerging economies. Major trends in the forecast period include increasing use of hypofractionated radiotherapy, adoption of image-guided radiotherapy, growth in mobile and remote radiotherapy units, integration of AI in treatment planning, expansion of patient-centric oncology care.Global Single Dose Radiotherapy Services Market Segmentation
1) By Type: Internal Beam Radiotherapy, External Beam Radiotherapy 2) By Application: Prostate Cancer, Breast Cancer 3) By Service Provider: Specialized Cancer Institutes, Radiotherapy Centers Subsegments: 1) By Internal Beam Radiotherapy: Brachytherapy, Intraoperative Radiotherapy (IORT) 2) By External Beam Radiotherapy: Stereotactic Radiosurgery (SRS), Stereotactic Body Radiotherapy (SBRT), Intensity-Modulated Radiotherapy (IMRT)What Is The Driver Of The Single Dose Radiotherapy Services Market?
The increase in cancer prevalence is anticipated to propel the market for single-dose radiotherapy services going forward. Cancer refers to a class of diseases characterized by uncontrolled cell growth, often forming tumors that can invade and spread to other parts of the body, impairing normal bodily functions. The prevalence of cancer is due to aging populations, lifestyle changes, environmental exposures, and advancements in detection and diagnosis. Single-dose radiotherapy services contribute to mitigating rising cancer prevalence by delivering swift, effective treatment that targets and eliminates cancer cells, potentially enhancing patient outcomes and lessening disease burden. For instance, in July 2024, according to the Australian Institute of Health and Welfare, an Australia-based government agency, In 2023, an estimated 165,000 Australians were newly diagnosed with cancer, which equates to over 450 cases each day, and males represented about 55% of these diagnoses. Therefore, the increase in cancer prevalence drives growth in the single-dose radiotherapy services market.Key Players In The Global Single Dose Radiotherapy Services Market
Major companies operating in the single dose radiotherapy services market are Hitachi Ltd, Varian Medical Systems Inc, Boston Scientific Corporation, Elekta AB, GenesisCare, Accuray Incorporated, IBA Dosimetry GmbH, ViewRay Inc, RaySearch Laboratories AB, RefleXion Medical Inc, Sensus Healthcare Inc, C-RAD AB, Panacea Medical Technologies Pvt Ltd, Advanced Oncotherapy Plc, ProTom International Inc, Isoray Inc, IntraOp Medical Corporation, Alliance Oncology, Nanobiotix, Xcision Medical Systems LLC, Oraya Therapeutics Inc, Mevion Medical Systems, Theragenics Corporation, Oncology Imaging SystemsGlobal Single Dose Radiotherapy Services Market Trends and Insights
Major companies operating in the single-dose radiotherapy services market are increasing their focus on developing innovative solutions, such as radiation therapy computed tomography (CT) solutions, to enhance imaging accuracy and simplify simulation workflows for oncology care. A new radiation therapy computed tomography (CT) solution is an advanced imaging system designed to improve the precision of radiation treatment, while the AI-enhanced version of the intelligent radiation therapy (iRT) platform incorporates artificial intelligence to optimize and personalize radiation therapy plans. For instance, in May 2024, GE HealthCare, a US-based medical technology company, launched Revolution RT and the Updated Intelligent Radiation Therapy (IRT) Platform. These solutions feature enhanced imaging accuracy, improved workflow efficiency, and AI-driven personalization, with the Revolution RT focusing on precise radiotherapy simulation and the updated iRT platform to streamline workflows and enhance precision. These technological advancements in radiotherapy significantly improve imaging accuracy and precision, simplify workflows, and enhance personalization and analytics capabilities, optimizing single-dose radiotherapy treatments for individual patients and increasing the efficiency, effectiveness, and accessibility of these services.What Are Latest Mergers And Acquisitions In The Single Dose Radiotherapy Services Market?
In May 2024, Novartis AG, a US-based healthcare company specializing in pharmaceuticals and biotechnology acquired Mariana Oncology, Inc. for an undisclosed amount. With this acquisition, Novartis AG aims to enhance its portfolio in precision medicine by integrating Mariana Oncology's innovative radioligand therapies, which are designed to target and treat cancer more effectively, thereby strengthening its position in the oncology market and advancing its commitment to delivering transformative treatments for patients. Mariana Oncology, Inc., is a US-based company with radioligand therapies for cancer treatment.Regional Outlook
North America was the largest region in the single dose radiotherapy services market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.What Defines the Single Dose Radiotherapy Services Market?
The single-dose radiotherapy services market includes revenues earned by entities by providing services such as palliative care services, radiation delivery, radiotherapy treatment planning, regular monitoring, and patient consultation and related linear accelerators, imaging systems, immobilization devices, beam shaping devices, and radiation safety equipment. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.How is Market Value Defined and Measured?
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.What Key Data and Analysis Are Included in the Single Dose Radiotherapy Services Market Report 2026?
The single dose radiotherapy services market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the single dose radiotherapy services industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.Single Dose Radiotherapy Services Market Report Forecast Analysis
| Report Attribute | Details |
|---|---|
| Market Size Value In 2026 | $1.73 billion |
| Revenue Forecast In 2035 | $2.27 billion |
| Growth Rate | CAGR of 8.1% from 2026 to 2035 |
| Base Year For Estimation | 2025 |
| Actual Estimates/Historical Data | 2020-2025 |
| Forecast Period | 2026 - 2030 - 2035 |
| Market Representation | Revenue in USD Billion and CAGR from 2026 to 2035 |
| Segments Covered | Type, Application, Service Provider |
| Regional Scope | Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa |
| Country Scope | The countries covered in the report are Australia, Brazil, China, France, Germany, India, ... |
| Key Companies Profiled | Hitachi Ltd, Varian Medical Systems Inc, Boston Scientific Corporation, Elekta AB, GenesisCare, Accuray Incorporated, IBA Dosimetry GmbH, ViewRay Inc, RaySearch Laboratories AB, RefleXion Medical Inc, Sensus Healthcare Inc, C-RAD AB, Panacea Medical Technologies Pvt Ltd, Advanced Oncotherapy Plc, ProTom International Inc, Isoray Inc, IntraOp Medical Corporation, Alliance Oncology, Nanobiotix, Xcision Medical Systems LLC, Oraya Therapeutics Inc, Mevion Medical Systems, Theragenics Corporation, Oncology Imaging Systems |
| Customization Scope | Request for Customization |
| Pricing And Purchase Options | Explore Purchase Options |
